| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |